Catalan researchers open door to a new treatment against colon cancer
Barcelona Institute for Research in Biomedicine’s finding employs use of immunology against colon cancer and its metastasis
Barcelona Institute for Research in Biomedicine’s finding employs use of immunology against colon cancer and its metastasis
A group of scientists from the Institute for Research in Biomedicine (IRB) at the Barcelona Institute of Science and Technology have identified a population of oral tumour cells which may feast on fats to spread throughout the body — a process called metastasis. According to the study, published this Wednesday in the prestigious scientific magazine ‘Nature’, some of these cells expressed high levels of a molecule called CD36, which helps cells to take up lipids from their environment. The research shows that applying antibodies that block CD36 and eliminate its interaction with fatty acids resulted in a reduced number of metastatic focus and also reduced their size by around 80% to 90%. “If we cut the lipids supply to those cells which generate metastasis they are practically unable to spread”, the leader of the IRB ‘Cancer and Stem cells’ team, Salvador Aznar Benitah, explained.